Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

511 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of high-dose immunoglobulins in dermatology.
Enk A, Fierlbeck G, French L, Hertl M, Messer G, Meurer M, Steinbrink K, Stingl G, Volc-Platzer B, Zillikens D. Enk A, et al. Among authors: hertl m. J Dtsch Dermatol Ges. 2009 Sep;7(9):806-812. doi: 10.1111/j.1610-0387.2009.07118.x. J Dtsch Dermatol Ges. 2009. PMID: 19624804 English, German.
Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age.
Rzany B, Partscht K, Jung M, Kippes W, Mecking D, Baima B, Prudlo C, Pawelczyk B, Messmer EM, Schuhmann M, Sinkgraven R, Büchner L, Büdinger L, Pfeiffer C, Sticherling M, Hertl M, Kaiser HW, Meurer M, Zillikens D, Messer G. Rzany B, et al. Among authors: hertl m. Arch Dermatol. 2002 Jul;138(7):903-8. doi: 10.1001/archderm.138.7.903. Arch Dermatol. 2002. PMID: 12071817
[The use of high dose intravenous immunoglobulins in dermatology].
Enk A, Hertl M, Messer G, Meurer M, Rentz E, Zillikens D. Enk A, et al. Among authors: hertl m. J Dtsch Dermatol Ges. 2003 Mar;1(3):183-90. doi: 10.1046/j.1610-0387.2003.02028.x. J Dtsch Dermatol Ges. 2003. PMID: 16285493 German.
Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseases.
Zillikens D, Derfler K, Eming R, Fierlbeck G, Goebeler M, Hertl M, Hofmann SC, Karlhofer F, Kautz O, Nitschke M, Opitz A, Quist S, Rose C, Schanz S, Schmidt E, Shimanovich I, Michael M, Ziller F. Zillikens D, et al. Among authors: hertl m. J Dtsch Dermatol Ges. 2007 Oct;5(10):881-7. doi: 10.1111/j.1610-0387.2007.06342.x. J Dtsch Dermatol Ges. 2007. PMID: 17910670 English, German.
Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases.
Hertl M, Zillikens D, Borradori L, Bruckner-Tuderman L, Burckhard H, Eming R, Engert A, Goebeler M, Hofmann S, Hunzelmann N, Karlhofer F, Kautz O, Lippert U, Niedermeier A, Nitschke M, Pfütze M, Reiser M, Rose C, Schmidt E, Shimanovich I, Sticherling M, Wolff-Franke S. Hertl M, et al. J Dtsch Dermatol Ges. 2008 May;6(5):366-73. doi: 10.1111/j.1610-0387.2007.06602.x. Epub 2008 Jan 14. J Dtsch Dermatol Ges. 2008. PMID: 18201220 English, German.
Allergological approach to drug hypersensitivity reactions.
Przybilla B, Aberer W, Bircher AJ, Brehler R, Brockow K, Dickel H, Fuchs T, Hertl M, Mockenhaupt M, Pfaar O, Ring J, Sachs B, Vieluf D, Wedi B, Worm M, Zuberbier T, Merk HF. Przybilla B, et al. Among authors: hertl m. J Dtsch Dermatol Ges. 2008 Mar;6(3):240-3. doi: 10.1111/j.1610-0387.2007.06656.x. Epub 2008 Jan 17. J Dtsch Dermatol Ges. 2008. PMID: 18205837 Review. English, German. No abstract available.
511 results